G&E Herbal Biotechnology Co., Ltd. (4911) Stock Price & Analysis
4911 Stock Chart & Stats
- Day’s Range
- TWD 23.85 - TWD 26.35
- 52-Week Range
- TWD 23.85 - TWD 46.48
- Previous Close
- TWD 26.50
- Volume
- N/A
- Average Volume (3M)
- 22.96K
- Market Cap
- TWD 1.72B
- Enterprise Value
- TWD 1.78B
- Total Cash (Recent Filing)
- TWD 425.82M
- Total Debt (Recent Filing)
- TWD 5.00M
- Price to Earnings (P/E)
- 18.7
- Beta
- 0.16
- Next Earnings
- Mar 16, 2027 (Est.)
- EPS Estimate
- N/A
- Last Dividend Ex-Date
- Jul 28, 2026
- Dividend Yield
- 4.66%
4911 FAQ
What was G&E Herbal Biotechnology Co., Ltd.’s price range in the past 12 months?
What is G&E Herbal Biotechnology Co., Ltd.’s market cap?
When is G&E Herbal Biotechnology Co., Ltd.’s upcoming earnings report date?
How were G&E Herbal Biotechnology Co., Ltd.’s earnings last quarter?
Is G&E Herbal Biotechnology Co., Ltd. overvalued?
Does G&E Herbal Biotechnology Co., Ltd. pay dividends?
What is G&E Herbal Biotechnology Co., Ltd.’s EPS estimate?
How many shares outstanding does G&E Herbal Biotechnology Co., Ltd. have?
What happened to G&E Herbal Biotechnology Co., Ltd.’s price movement after its last earnings report?
Which hedge fund is a major shareholder of G&E Herbal Biotechnology Co., Ltd.?
What is the TipRanks Smart Score and how is it calculated?
Company Description
G&E Herbal Biotechnology Co., Ltd.
G&E Herbal Biotechnology Co., Ltd. operates as a biopharmaceutical enterprise, concentrating on the innovation and commercialization of advanced botanical extraction technologies and the products derived from them. Its diverse portfolio features a range of botanical anti-aging cosmetic items, including facial foam cleansers, cleansing essences, toners, lightening lotions, essential oils, and moisturizing serums and creams, along with specialized products like the SR-100 botanical essence and bromelain illuminating cleansing mousse. The company also manufactures capsules designed as hepato-protective agents. In the realm of wellness, G&E offers a selection of botanical healthcare products such as ArthrEnergy, Jujubes Polysaccharide, Diabecut, HepatoClean, Astragali Radix, Goji, Prosta, and SR-100 capsules, as well as various products catering to adults. Looking to its future developments, the company is actively pursuing new treatments, including Solarise injection for gynecologic, head, and neck cancers; Apocin capsules intended for non-small cell lung cancer; and SR-T100 Gel, which targets common and genital warts. Beyond its own product lines, G&E Herbal Biotechnology is involved in creating manufacturing technologies for a wide array of dietary supplements and provides expert technical advisory services to other biotechnology organizations. The company was founded in 2002 and is headquartered in Tainan City, Taiwan.
- Sector
- General
- Industry
- Biotechnology
- CEO
- Kou-Wha Kou
- Employees
- 38
- Website
- www.geherbs.com.tw
- Address
- No.92, Keji 5th Road, Tainan City, TQ, 709015, CN
G&E Herbal Biotechnology Co., Ltd. (4911) Earnings & Revenues
Technical Analysis
Overall Consensus
| Indicator | Bullish | Neutral | Bearish |
|---|---|---|---|
| Overall Consensus | 3 | 5 | 14 |
| Technical Analysis | 3 | 5 | 2 |
| Moving Averages | 0 | 0 | 12 |
